| Year |
Citation |
Score |
| 2016 |
Harbeck N, Huang CS, Hurvitz S, Yeh DC, Shao Z, Im SA, Jung KH, Shen K, Ro J, Jassem J, Zhang Q, Im YH, Wojtukiewicz M, Sun Q, Chen SC, et al. Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial. The Lancet. Oncology. PMID 26822398 DOI: 10.1016/S1470-2045(15)00540-9 |
0.333 |
|
| 2015 |
Wang LP, Cao J, Zhang J, Wang BY, Hu XC, Shao ZM, Wang ZH, Ou ZL. The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells. Medical Oncology (Northwood, London, England). 32: 254. PMID 26487662 DOI: 10.1007/s12032-015-0696-6 |
0.365 |
|
| 2015 |
Chen L, Yang L, Qiao F, Hu X, Li S, Yao L, Yang XL, Shao ZM. High Levels of Nucleolar Spindle-Associated Protein and Reduced Levels of BRCA1 Expression Predict Poor Prognosis in Triple-Negative Breast Cancer. Plos One. 10: e0140572. PMID 26485712 DOI: 10.1371/journal.pone.0140572 |
0.333 |
|
| 2015 |
Chi Y, Huang S, Peng H, Liu M, Zhao J, Shao Z, Wu J. Critical role of CDK11(p58) in human breast cancer growth and angiogenesis. Bmc Cancer. 15: 701. PMID 26470709 DOI: 10.1186/s12885-015-1698-7 |
0.316 |
|
| 2015 |
Yu KD, Wang X, Yang C, Zeng XH, Shao ZM. Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse. Oncotarget. PMID 26314842 DOI: 10.18632/oncotarget.4470 |
0.33 |
|
| 2006 |
Lu JS, Li HC, Cao DC, Di GH, Wu J, Shen KW, Shen ZZ, Shao ZM. [Clinicopathological significance of aromatase expression in breast cancers]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 44: 1318-21. PMID 17217816 |
0.599 |
|
| 2005 |
Di GH, Lu JS, Song CG, Li HC, Shen ZZ, Shao ZM. Over expression of aromatase protein is highly related to MMPs levels in human breast carcinomas. Journal of Experimental & Clinical Cancer Research : Cr. 24: 601-7. PMID 16471323 |
0.612 |
|
| 2005 |
Hou YF, Yuan ST, Li HC, Wu J, Lu JS, Lu LJ, Liu G, Shen ZZ, Ding J, Shao ZM. [In vitro study of the effects of estrogen receptor beta expression on the biological behavior of a human breast cancer cell line]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 27: 389-92. PMID 16188119 |
0.565 |
|
| 2005 |
Shen Z, Wu Q, Yue L, Li HC, Shen ZZ, Shao ZM. [Function and prognostic value of tumor suppressor gene LKB1 in human breast carcinoma]. Zhonghua Yi Xue Za Zhi. 85: 15-8. PMID 15808068 |
0.591 |
|
| 2004 |
Li HC, Cao DC, Liu Y, Hou YF, Wu J, Lu JS, Di GH, Liu G, Li FM, Ou ZL, Jie C, Shen ZZ, Shao ZM. Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma. Breast Cancer Research and Treatment. 88: 75-85. PMID 15538048 DOI: 10.1007/s10549-004-1200-8 |
0.555 |
|
| 2004 |
Hou YF, Yuan ST, Li HC, Wu J, Lu JS, Liu G, Lu LJ, Shen ZZ, Ding J, Shao ZM. ERbeta exerts multiple stimulative effects on human breast carcinoma cells. Oncogene. 23: 5799-806. PMID 15208676 DOI: 10.1038/sj.onc.1207765 |
0.607 |
|
| 2003 |
Di GH, Li HC, Shen ZZ, Shao ZM. [Analysis of anti-proliferation of curcumin on human breast cancer cells and its mechanism]. Zhonghua Yi Xue Za Zhi. 83: 1764-8. PMID 14642080 |
0.59 |
|
| 2003 |
Li HC, Wen XF, Hou YF, Shen KW, Wu J, Lu JS, Shen ZZ, Shao ZM. Addition of adjuvant tamoxifen to cyclophosphamide, methotrexate and 5-fluorouracil for premenopausal women with oestrogen receptor-positive breast cancer. Asian Journal of Surgery / Asian Surgical Association. 26: 163-8. PMID 12925292 DOI: 10.1016/S1015-9584(09)60377-8 |
0.564 |
|
| Show low-probability matches. |